To support the development of next-gen therapies, including GLP-1 drugs for diabetes and obesity.

Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...

The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).

Alloy Therapeutics Inc., a biotechnology ecosystem company, has joined forces with Pfizer Inc., to develop a new platform ...

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...

Brings together Tabshield ready-to-use film coating systems and ReadiLYCOAT plant-based ready-to-use coating systems.

Novartis has agreed to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical ...

Telix Pharmaceuticals Ltd.’s prostate cancer PET imaging agent Illuccix has been approved by the Danish Medicines Agency.

The project is set to become the largest GMP temperature-controlled facility fully dedicated to the life sciences sector in ...

Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...

Addresses the significant threat of antimicrobial resistance.